Bedrosian Camille L insider trades
Bedrosian Camille L has filed 29 Form 4s with the SEC that we hold, for Amylyx Pharmaceuticals, Inc. (AMLX) (Chief Medical Officer), Crinetics Pharmaceuticals, Inc. (CRNX) (Director), Rhythm Pharmaceuticals, INC. (RYTM) (Director) and Ultragenyx Pharmaceutical Inc. (RARE) (EVP and Chief Medical Officer). Across all of them we count 0 purchases worth $0 and 14 sales worth $1.8M reported on Form 4. In the last 12 months: 0 purchases ($0) and 4 sales ($513.5K). The largest single trade was a sale of 7,947 shares of Amylyx Pharmaceuticals, Inc. worth $256.0K, dated 2026-09-10. Of 2 sales filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-09-02 and the latest 2026-09-14.
Amylyx Pharmaceuticals, Inc. (AMLX)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2024-09-30 | S, sale reported on Form 4 | 11,442 | $36.6K | 2024-10-02 | SEC |
| 2024-12-02 | S, sale reported on Form 4 | 5,421 | $30.0K | 2024-12-03 | SEC |
| 2025-03-31 | S, sale reported on Form 4 | 12,425 | $43.1K | 2025-04-02 | SEC |
| 2025-09-30 | S, sale reported on Form 4 | 12,039 | $175.5K | 2025-10-02 | SEC |
| 2025-12-01 | S, sale reported on Form 4 | 6,580 | $94.4K | 2025-12-03 | SEC |
| 2026-03-02 | S, sale reported on Form 4 | 6,461 | $94.2K | 2026-03-04 | SEC |
| 2026-09-10 | S, sale reported on Form 4 | 7,947 | $256.0K | 2026-09-14 | SEC |
| 2026-09-10 | S, sale reported on Form 4 | 2,081 | $68.9K | 2026-09-14 | SEC |
Crinetics Pharmaceuticals, Inc. (CRNX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Rhythm Pharmaceuticals, INC. (RYTM)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Ultragenyx Pharmaceutical Inc. (RARE)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2021-09-01 | S, sale reported on Form 4 | 2,500 | $250.1K | 2021-09-02 | SEC |
| 2021-09-02 | S, sale reported on Form 4 | 2,500 | $250.5K | 2021-09-02 | SEC |
| 2021-10-14 | S, sale reported on Form 4 | 359 | $29.1K | 2021-10-18 | SEC |
| 2022-01-30 | S, sale reported on Form 4 | 1,657 | $109.9K | 2022-02-01 | SEC |
| 2022-03-01 | S, sale reported on Form 4 | 2,821 | $187.9K | 2022-03-03 | SEC |
| 2023-03-01 | S, sale reported on Form 4 | 3,881 | $175.6K | 2023-03-03 | SEC |
Counted from the Form 4 filings this reporting owner (SEC CIK 1326969) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
